LY3041658 is (expected to be a) monoclonal antibody that targets and specifically bind seven human ELR+ CXC chemokines. Such antibodies are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer.
Showing posts with label Chemokine Antagonist. Show all posts
Showing posts with label Chemokine Antagonist. Show all posts
Subscribe to:
Posts (Atom)